The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2007, 179, 2055 -2059
Copyright © 2007 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dobbs, A. K.
Right arrow Articles by Conley, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dobbs, A. K.
Right arrow Articles by Conley, M. E.

Cutting Edge: A Hypomorphic Mutation in Igbeta (CD79b) in a Patient with Immunodeficiency and a Leaky Defect in B Cell Development1

A. Kerry Dobbs*, Tianyu Yang*, Dana Farmer*, Leo Kager{dagger}, Ornella Parolini{ddagger} and Mary Ellen Conley2,*,§

* Department of Immunology, St. Jude Children’s Research Hospital, Memphis, TN 38105; {dagger} Department of Hematology/Oncology, St. Anna Children’s Hospital, Vienna, Austria; {ddagger} Centro di Ricerca E. Menni, Fondazione Poliambulanza, Brescia, Italy; and § Department of Pediatrics, University of Tennessee, Memphis, TN 38163

Although null mutations in Ig{alpha} have been identified in patients with defects in B cell development, no mutations in Igbeta have been reported. We recently identified a patient with a homozygous amino acid substitution in Igbeta, a glycine to serine at codon 137, adjacent to the cysteine required for the disulfide bond between Ig{alpha} and Igbeta. This patient has a small percentage of surface IgMdim B cells in the peripheral circulation (0.08% compared with 5–20% in healthy controls). Using expression vectors in 293T cells or Jurkat T cells, we show that the mutant Igbeta can form disulfide-linked complexes and bring the µ H chain to the cell surface as part of the BCR but is inefficient at both tasks. The results show that minor changes in the ability of the Ig{alpha}/Igbeta complex to bring the BCR to the cell surface have profound effects on B cell development.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 These studies were supported in part by National Institutes of Health Grant AI25129, National Cancer Institute Grant P30 CA21765, American Lebanese Syrian Associated Charities, and funds from the Federal Express Chair of Excellence.

2 Address correspondence and reprint requests to Dr. Mary Ellen Conley, University of Tennessee College of Medicine, St. Jude Children’s Research Hospital, 332 North Lauderdale, Memphis, TN 38105. E-mail address: maryellen.conley{at}stjude.org

3 Abbreviations used in this paper: SSCP, single-stranded conformational polymorphism; MSCV, mouse stem cell virus; YFP, yellow fluorescent protein.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.